CHRISTIE CHRISTOPHER — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
CHRISTIE CHRISTOPHER has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Christopher Christie is listed as a director of Pacira BioSciences, Inc. in SEC filings as of 2026-06-13. The available SEC context identifies him solely as a director and does not provide a public biography or background. Pacira BioSciences is a biotechnology company focused on non-opioid pain management therapies, including Exparel. Beyond the director role, publicly available information in the filing does not disclose prior positions, education, or other corporate affiliations for this individual.
Role
Director
Notability
25/100
Board memberships
Pacira BioSciences, Inc.
Awards & honors
Not disclosed in SEC filing; no publicly documented achievements available in this context.
Christopher Christie is listed as a director of Pacira BioSciences, Inc. in SEC filings as of 2026-06-13. The available SEC context identifies him solely as a director and does not provide a public biography or background. Pacira BioSciences is a biotechnology company focused on non-opioid pain management therapies, including Exparel. Beyond the director role, publicly availabl…
How many SEC Form 4 filings has CHRISTIE CHRISTOPHER submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of CHRISTIE CHRISTOPHER's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
